TOP TIERMARKET NEWSWIRE
SEC Form 4 history

LYELL IMMUNOPHARMA I (LYEL) insider trades

LYELL IMMUNOPHARMA I (LYEL) insider trading activity (SEC Form 4). Over the trailing 90 days, LYEL insiders filed 0 purchases totalling $0 and 7 sales totalling $41K — net SELLING of $41K. Most recent filing: Jul 20, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
7
$41K
Net (90d)
-$41K
net selling
Most recent
Jul 20, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 20, 2026Innovative Cellular Therapeutics Holdings Ltd10%S Sale—$13.70$137filing
Jul 17, 2026Innovative Cellular Therapeutics Holdings Ltd10%S Sale—$13.73$137filing
Jun 11, 2026Shook DavidChief Medical OfficerS Sale—$12.64$25Kfiling
Jun 15, 2026Seely LynnPres, CEOS Sale—$18.91$7Kfiling
Jun 15, 2026Hill Stephen J.COOS Sale—$18.92$2Kfiling
Jun 15, 2026Lee Gary K.Chief Scientific OfficerS Sale—$18.92$2Kfiling
Jun 15, 2026Bulis Veronica SanchezVP, Corporate ControllerS Sale—$18.91$4Kfiling